Skip to main content
. 2019 Apr 18;40(10):1279–1291. doi: 10.1038/s41401-019-0220-1

Fig. 11.

Fig. 11

A proposed model illustrating the mechanism that underlies NTZ in the amelioration of AD pathology. NTZ stimulated autophagy and promoted Aβ clearance by inhibiting both PI3K/AKT/mTOR/ULK1 and NQO1/mTOR/ULK1 signaling pathways. NTZ was capable of repressing tau hyperphosphorylation involving inhibition of PI3K/AKT/GSK3β pathway and attenuating LPS-induced inflammation by inhibiting PI3K/AKT/IκB/NFκB signaling